Inventor
GASTWIRT RANDY
US13 patents
⚠️ This page may combine multiple inventors who share the name “GASTWIRT RANDY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SORRENTO THERAPEUTICS INC
11 patentsUS10058609B2Aug 28, 2018
Antigen binding proteins that bind PD-L1
SORRENTO THERAPEUTICS INC17 citations93
US10519245B2Dec 31, 2019
Antibodies which bind insulin-like growth factor receptor-1 (IGF1R) and methods of use thereof to treat cancer
SORRENTO THERAPEUTICS INC6 citations83
US10377827B2Aug 13, 2019
Antigen binding proteins that bind c-met
SORRENTO THERAPEUTICS INC14 citations83
US12084503B2Sep 10, 2024
Fully human antibodies that bind to vascular endothelial growth factor receptor 2 (VEGFR2) and methods of use thereof for treatment
SORRENTO THERAPEUTICS INC2 citations72
US11878058B2Jan 23, 2024
Antigen binding proteins that bind PD-L1
SORRENTO THERAPEUTICS INC0 citations62
US11111304B2Sep 7, 2021
Fully human antibodies that bind to vascular endothelial growth factor receptor 2 (VEGFR2)
SORRENTO THERAPEUTICS INC0 citations62
US11027012B2Jun 8, 2021
Antigen binding proteins that bind PD-L1
SORRENTO THERAPEUTICS INC0 citations62
US11155628B2Oct 26, 2021
Antigen binding proteins that bind c-Met
SORRENTO THERAPEUTICS INC0 citations60
US10174107B2Jan 8, 2019
Antigen binding proteins that bind delta-like 4 (DLL-4)
SORRENTO THERAPEUTICS INC1 citations60
US9944707B2Apr 17, 2018
Antibodies that bind epidermal growth factor receptor (EGFR)
SORRENTO THERAPEUTICS INC1 citations51
US10717779B2Jul 21, 2020
Methods for blocking an interaction between notch-1 and delta-like 4 (DLL-4) by administering a DDL-4 antibody
SORRENTO THERAPEUTICS INC0 citations50